BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34957924)

  • 21. Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
    Kim JS; Hahn JS; Park SY; Kim Y; Park IH; Lee CK; Cheong JW; Lee ST; Min YH
    Yonsei Med J; 2007 Feb; 48(1):78-89. PubMed ID: 17326249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China.
    Wang C; Xia B; Ning Q; Zhao H; Yang H; Zhao Z; Wang X; Wang Y; Yu Y; Zhang Y
    Ann Hematol; 2018 Mar; 97(3):453-457. PubMed ID: 29188315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
    Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
    J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
    Li YY; Hu DZ; Wang YF; Zhao ZG; Cao Z; Zhang YZ; Zhang HL; Tian C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):849-854. PubMed ID: 32552946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation of hepatitis B virus infection to non-Hodgkin's lymphoma].
    Qin XT; Lu Y; Chen XQ; Xu HP; Fan HJ
    Ai Zheng; 2007 Mar; 26(3):294-7. PubMed ID: 17355794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of hepatitis B virus surface antigen in 120 Hodgkin's lymphoma patients.
    Qiu MZ; Ruan DY; Wang ZQ; Luo HY; Teng KY; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Xu RH
    Chin J Cancer; 2010 Aug; 29(8):735-40. PubMed ID: 20663320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.
    Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM
    Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
    Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
    J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of tumour-associated macrophages in Non-Hodgkin's lymphoma: A systematic review and meta-analysis.
    Xu X; Li Z; Liu J; Zhu F; Wang Z; Wang J; Zhang J; Wang H; Zhai Z
    Scand J Immunol; 2020 Jan; 91(1):e12814. PubMed ID: 31419843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy.
    Guo W; Zhang W; Liu C; Song Y; Bai O
    PLoS One; 2015; 10(6):e0129064. PubMed ID: 26053951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection.
    Ulcickas Yood M; Quesenberry CP; Guo D; Caldwell C; Wells K; Shan J; Sanders L; Skovron ML; Iloeje U; Manos MM
    Hepatology; 2007 Jul; 46(1):107-12. PubMed ID: 17526021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
    Yamauchi N; Maruyama D; Choi I; Atsuta Y; Sakai R; Miyashita K; Moriuchi Y; Tsujimura H; Kubota N; Yamamoto G; Igarashi T; Izutsu K; Yoshida S; Kojima K; Uchida T; Inoue Y; Tsukamoto N; Ohtsuka E; Suzuki S; Inaguma Y; Ichikawa S; Gomyo H; Ushijima Y; Nosaka K; Kurata M; Tanaka Y; Ueda R; Mizokami M; Kusumoto S
    Cancer Sci; 2021 May; 112(5):1943-1954. PubMed ID: 33576088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
    Drake MT; Maurer MJ; Link BK; Habermann TM; Ansell SM; Micallef IN; Kelly JL; Macon WR; Nowakowski GS; Inwards DJ; Johnston PB; Singh RJ; Allmer C; Slager SL; Weiner GJ; Witzig TE; Cerhan JR
    J Clin Oncol; 2010 Sep; 28(27):4191-8. PubMed ID: 20713849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.
    Kuniyoshi M; Nakamuta M; Sakai H; Enjoji M; Kinukawa N; Kotoh K; Fukutomi M; Yokota M; Nishi H; Iwamoto H; Uike N; Nishimura J; Inaba S; Maeda Y; Nawata H; Muta K
    J Gastroenterol Hepatol; 2001 Feb; 16(2):215-9. PubMed ID: 11207904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic hepatitis B virus infection is associated with a poorer prognosis in diffuse large B-cell lymphoma: a meta-analysis and systemic review.
    Rong X; Wang H; Ma J; Pan S; Wang H; Jing S; Su Y; Wang L; Zhao C
    J Cancer; 2019; 10(15):3450-3458. PubMed ID: 31293649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy.
    Lee GW; Ryu MH; Lee JL; Oh S; Kim E; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Kim WK; Lee JS; Kang YK
    J Korean Med Sci; 2003 Dec; 18(6):849-54. PubMed ID: 14676442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
    J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.
    Zhang Y; Chen MB; Zhou XY; Hong XN
    PLoS One; 2013; 8(6):e66411. PubMed ID: 23840460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies.
    Dalia S; Chavez J; Castillo JJ; Sokol L
    Leuk Res; 2013 Sep; 37(9):1107-15. PubMed ID: 23809055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.